BIOMAKERS: Valuation, Funding & Investors
BIOMAKERS is a precision medicine and oncology intelligence company that integrates large-scale molecular diagnostics, longitudinal real-world clinical data, and a diverse tumor biobank to support therapeutic and diagnostic development. The company operates across Latin America and the United States, linking genomic data to biospecimens and clinical outcomes and deploying AI technologies to harmonize clinical data and enable precision oncology research at scale.
Leadership & Board
- Current Number of Employees
- 78
- Current LinkedIn Followers
- 17,888
Latest Estimated Valuation
- Total Amount Raised
- $8M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $8M
- Latest Funding Round
- Investment
Employee Trend
BIOMAKERS had 78 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
BIOMAKERS had 17,888 followers as of November 16, 2026. The number of followers increased by 18 (0.10%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 20, 2026 | Investment | $8.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Oncology Ventures | Investment |
| Endurance28 | Investment |
| Labcorp Venture Fund | Investment |
| Zentynel | Investment |
| Sonen Capital | Investment |
| Sky High Fund | Investment |
Similar Companies
A snapshot of private companies similar to BIOMAKERS, helping you discover and navigate related company profiles.
Related News and Analysis








